August 7, 2012
Astellas Pharma announced on August 6 that it will close its US subsidiary Urogenix Inc. (North Carolina), a drug discovery research facility for urological diseases, by the end of December. Its research projects will be transferred to Astellas’s Tsukuba Research...read more